NEW YORK (GenomeWeb News) — Celera today said it has closed its $33 million acquisition of Atria Genetics, a maker of human leukocyte antigen-testing products used in organ donor matching.
 
Celera said it plans to integrate all of Atria’s 13 employees into its company.
 
Celera also said it expects the acquisition will be accretive to its earnings by the second half of 2008.
 
The company disclosed its plans to buy the South San Francisco, Calif.-based company last month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.